A functional variant in NKX3.1 associated with prostate cancer susceptibility down-regulates NKX3.1 expression

Human Molecular Genetics

Volumn 19, Issue 21, 2010, Pages 4265-4272

  Akamatsu, Shusuke ^a,b   Takata, Ryo ^a,c   Ashikawa, Kyota ^a   Hosono, Naoya ^a   Kamatani, Naoyuki ^a   Fujioka, Tomoaki ^c   Ogawa, Osamu ^b   Kubo, Michiaki ^a   Nakamura, Yusuke ^d   Nakagawa, Hidewaki ^a  

^a RIKEN   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c IWATE MEDICAL UNIVERSITY   (Japan)

^d THE UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR PROTEIN; PROTEIN NKX3.1; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; BINDING AFFINITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE LOCUS; GENE MAPPING; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; RNA STABILITY; SINGLE NUCLEOTIDE POLYMORPHISM;

5' UNTRANSLATED REGIONS; ALLELES; DOWN-REGULATION; GENETIC PREDISPOSITION TO DISEASE; HOMEODOMAIN PROTEINS; HUMANS; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 77957878164     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq350     Document Type: Article

References (30)

1. Hsing, A. and Devesa, S. (2001) Trends and patterns of prostate cancer: what do they suggest? Epidemiol. Rev., 23, 3-13.
2. Grönberg, H. (2003) Prostate cancer epidemiology. Lancet, 361, 859-864.
3. Matsuda, T. and Saika, K. (2009) Comparison of time trends in prostate cancer incidence (1973-2002) in Asia, from cancer incidence in five continents, Vols IV-IX. Jpn J. Clin. Oncol., 39, 468-469.
4. Lichtenstein, P., Holm, N., Verkasalo, P., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A. and Hemminki, K. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med., 343, 78-85.
5. Schaid, D. (2004) The complex genetic epidemiology of prostate cancer. Hum. Mol. Genet., 13 (Spec no. 1), R103-R121.
6. Eeles, R., Kote-Jarai, Z., Giles, G., Olama, A., Guy, M., Jugurnauth, S., Mulholland, S., Leongamornlert, D., Edwards, S., Morrison, J. et al. (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat. Genet., 40, 316-321.
7. Eeles, R., Kote-Jarai, Z., Al Olama, A., Giles, G., Guy, M., Severi, G., Muir, K., Hopper, J., Henderson, B., Haiman, C. et al. (2009) Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat. Genet., 41, 1116-1121.
8. Gudmundsson, J., Sulem, P., Rafnar, T., Bergthorsson, J., Manolescu, A., Gudbjartsson, D., Agnarsson, B., Sigurdsson, A., Benediktsdottir, K., Blondal, T. et al. (2008) Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat. Genet., 40, 281-283.
9. Gudmundsson, J., Sulem, P., Gudbjartsson, D., Blondal, T., Gylfason, A., Agnarsson, B., Benediktsdottir, K., Magnusdottir, D., Orlygsdottir, G., Jakobsdottir, M. et al. (2009) Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat. Genet., 41, 1122-1126.
10. Amundadottir, L., Sulem, P., Gudmundsson, J., Helgason, A., Baker, A., Agnarsson, B., Sigurdsson, A., Benediktsdottir, K., Cazier, J., Sainz, J. et al. (2006) A common variant associated with prostate cancer in European and African populations. Nat. Genet., 38, 652-658.
11. Thomas, G., Jacobs, K., Yeager, M., Kraft, P., Wacholder, S., Orr, N., Yu, K., Chatterjee, N., Welch, R., Hutchinson, A. et al. (2008) Multiple loci identified in a genome-wide association study of prostate cancer. Nat. Genet., 40, 310-315.
12. Chang, B., Cramer, S., Wiklund, F., Isaacs, S., Stevens, V., Sun, J., Smith, S., Pruett, K., Romero, L., Wiley, K. et al. (2009) Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. Hum. Mol. Genet., 18, 1368-1375.
13. He, W., Sciavolino, P., Wing, J., Augustus, M., Hudson, P., Meissner, P., Curtis, R., Shell, B., Bostwick, D., Tindall, D. et al. (1997) A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics, 43, 69-77.
14. Bhatia-Gaur, R., Donjacour, A., Sciavolino, P., Kim, M., Desai, N., Young, P., Norton, C., Gridley, T., Cardiff, R., Cunha, G. et al. (1999) Roles for Nkx3.1 in prostate development and cancer. Genes Dev., 13, 966-977.
15. Wang, X., Kruithof-de Julio, M., Economides, K., Walker, D., Yu, H., Halili, M., Hu, Y., Price, S., Abate-Shen, C. and Shen, M. (2009) A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature, 461, 495-500.
16. Bova, G., Carter, B., Bussemakers, M., Emi, M., Fujiwara, Y., Kyprianou, N., Jacobs, S., Robinson, J., Epstein, J. and Walsh, P. (1993) Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res., 53, 3869-3873.
17. Takata, R., Akamatsu, S., Kubo, M., Takahashi, A., Hosono, N., Kawaguchi, T., Tsunoda, T., Inazawa, J., Kamatani, N., Ogawa, O. et al. (2010) Genome-wide association study identifies multiple new susceptibility loci for prostate cancer in Japanese population. Nat. Genet., doi: 10.1038/ng.635.
18. de Moor, C., Meijer, H. and Lissenden, S. (2005) Mechanisms of translational control by the 3′ UTR in development and differentiation. Semin. Cell Dev. Biol., 16, 49-58.
19. Hughes, T. (2006) Regulation of gene expressi on by alternative untranslated regions. Trends Genet., 22, 119-122.
20. Mazumder, B., Seshadri, V. and Fox, P. (2003) Translational control by the 3′-UTR: the ends specify the means. Trends Biochem. Sci., 28, 91-98.
21. Bartel, D. (2009) MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-233.
22. Heinemeyer, T., Wingender, E., Reuter, I., Hermjakob, H., Kel, A., Kel, O., Ignatieva, E., Ananko, E., Podkolodnaya, O., Kolpakov, F. et al. (1998) Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res., 26, 362-367.
23. Voeller, H., Augustus, M., Madike, V., Bova, G., Carter, K. and Gelmann, E. (1997) Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers. Cancer Res., 57, 4455-4459.
24. Zheng, S., Ju, J., Chang, B., Ortner, E., Sun, J., Isaacs, S., Wiley, K., Liu, W., Zemedkun, M., Walsh, P. et al. (2006) Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function. Cancer Res., 66, 69-77.
25. Asatiani, E., Huang, W., Wang, A., Rodriguez Ortner, E., Cavalli, L., Haddad, B. and Gelmann, E. (2005) Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer. Cancer Res., 65, 1164-1173.
26. Markowski, M., Bowen, C. and Gelmann, E. (2008) Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3.1. Cancer Res., 68, 6896-6901.
27. Chorley, B., Wang, X., Campbell, M., Pittman, G., Noureddine, M. and Bell, D. (2008) Discovery and verification of functional single nucleotide polymorphisms in regulatory genomic regions: current and developing technologies. Mutat. Res., 659, 147-157.
28. Thomas, M., Preece, D. and Bentel, J. (2010) Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3′ untranslated region. Biochem. J., 425, 575-583.
29. Nakamura, Y. (2007) The BioBank Japan Project. Clin. Adv. Hematol. Oncol., 5, 696-697.
30. Ohnishi, Y., Tanaka, T., Ozaki, K., Yamada, R., Suzuki, H. and Nakamura, Y. (2001) A high-throughput SNP typing system for genome-wide association studies. J. Hum. Genet., 46, 471-477.